| 000 | 01463 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513203752.0 | ||
| 264 | 0 | _c20000418 | |
| 008 | 200004s 0 0 eng d | ||
| 022 | _a0042-6822 | ||
| 024 | 7 |
_a10.1006/viro.1999.0130 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avon Herrath, M G | |
| 245 | 0 | 0 |
_aVaccination to treat persistent viral infection. _h[electronic resource] |
| 260 |
_bVirology _cMar 2000 |
||
| 300 |
_a411-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdoptive Transfer |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aEpitopes, T-Lymphocyte _ximmunology |
| 650 | 0 | 4 |
_aLipoproteins _xchemistry |
| 650 | 0 | 4 |
_aLymphocytic Choriomeningitis _xdrug therapy |
| 650 | 0 | 4 |
_aLymphocytic choriomeningitis virus _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNucleoproteins _ximmunology |
| 650 | 0 | 4 |
_aPeptides _ximmunology |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 |
_aVaccines, Inactivated _ximmunology |
| 650 | 0 | 4 |
_aViral Proteins _ximmunology |
| 650 | 0 | 4 |
_aViral Vaccines _ximmunology |
| 700 | 1 | _aBerger, D P | |
| 700 | 1 | _aHomann, D | |
| 700 | 1 | _aTishon, T | |
| 700 | 1 | _aSette, A | |
| 700 | 1 | _aOldstone, M B | |
| 773 | 0 |
_tVirology _gvol. 268 _gno. 2 _gp. 411-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/viro.1999.0130 _zAvailable from publisher's website |
| 999 |
_c10658411 _d10658411 |
||